SAN DIEGO, Oct. 3 /PRNewswire-FirstCall/ -- Protein Polymer Technologies,
Inc. (OTC Bulletin Board: PPTI), a biotechnology device company that is a
pioneer in protein design and synthesis, announced today the addition of
Stephen Reitzler as Vice President, Clinical and Regulatory Affairs, effective
October 3, 2005. Reitzler's responsibilities will include strategic and
executional oversight for all U.S. clinical and regulatory matters, including
filings and interaction with regulatory authorities.
Reitzler joins PPTI with more than twenty-five years of experience in the
strategic management of regulatory, compliance and clinical research. Prior
to joining the company, Mr. Reitzler served as V.P. Regulatory Affairs and
Quality Assurance for INNERCOOL therapies and previously was V.P. Regulatory
Affairs and Quality Assurance for NuVasive Incorporated. He has broad
experience in both 510 (k) and PMA applications, and ISO/FDA GMP audits.
"Stephen brings exceptional clinical and regulatory expertise to PPTI and
we welcome him to our executive team," said William N. Plamondon III, PPTI's
Chief Executive Officer. "His impressive background will prove to be
extremely valuable and further strengthen our leadership in clinical and
regulatory affairs as we advance toward the important product development
milestones that we have set for the company."
Mr. Reitzler played an important role at United States Surgical
Corporation, a highly successful medical device company that took a creative
and cutting edge approach to the Food and Drug Administration process. He also
helped start a highly successful and large consulting practice in San Diego,
Advanced Bioresearch Associates, where he was head of regulatory affairs and
worked on a variety of projects such as an implantable heart, an artificial
liver and a chemotherapy drug.
"I am excited to join PPTI at this point in its transformation and am
confident that my experience can add value as we go forward and execute our
development and commercialization strategies," commented Mr. Reitzler. "I am
impressed by the current product pipeline and the value that it will provide."
About Protein Polymer Technologies, Inc.
Protein Polymer Technologies, Inc. is a biotechnology company that
discovers and develops innovative therapeutic devices to improve medical and
surgical outcomes. The Company focuses on developing technology and products
to be used for soft tissue augmentation, tissue adhesives and sealants, wound
healing support and drug delivery devices. Protein Polymer Technologies'
proprietary protein-based biomaterials are uniquely tailored to optimize
clinical performance and contain no human or animal components that could
potentially transmit or cause disease. The company is headquartered in San
Diego, California. For additional information about the company, please visit
http://www.ppti.com.
To date, PPTI has been issued twenty-six U.S. Patents on its core
technology with corresponding issued and pending patents in key international
markets.
This press release contains forward-looking statements that are based on
management's views and expectations. Actual results could differ materially
from those expressed here; further, the Company is not obligated to comment
specifically on those differences. Risks associated with the Company's
activities include raising adequate capital to continue operations scientific
and product development uncertainties, competitive products and approaches,
continuing collaborative partnership interest and funding, regulatory testing
and approvals, and manufacturing scale up. The reader is encouraged to refer
to the Company's 2004 Annual Report Form 10-KSB, and 10KSB/A and other recent
filings with the Securities and Exchange Commission, copies of which are
available from the Company, to further ascertain the risks associated with the
above statements.
SOURCE Protein Polymer Technologies, Inc.
 back to top
Related links:
http://www.ppti.com
CONTACT:
Erin Davis of Protein Polymer Technologies,
Inc., +1-858-558-6064, ext. 120, or Carole Boucard,
+1-954-370-2524, or Bryan deCastro, +1-631-495-9177, both of
Creative Public Relations, for Polymer Technologies
|
